After implicating Axl in cetuximab resistance, we sought to explore the impact of targeting the TAM receptors in solid tumors, including HNSCC, NSCLC, and TNBC, with the hypothesis that Axl inhibition would impact proliferation, survival, and metastasis. The gene discussed is AXL; the disease is non-small cell lung carcinoma.